ATE261959T1 - Substituierte phenyl-piperazin-derivate, deren herstellung und verwendung - Google Patents

Substituierte phenyl-piperazin-derivate, deren herstellung und verwendung

Info

Publication number
ATE261959T1
ATE261959T1 AT00984924T AT00984924T ATE261959T1 AT E261959 T1 ATE261959 T1 AT E261959T1 AT 00984924 T AT00984924 T AT 00984924T AT 00984924 T AT00984924 T AT 00984924T AT E261959 T1 ATE261959 T1 AT E261959T1
Authority
AT
Austria
Prior art keywords
preparation
substituted phenyl
piperazine derivatives
piperazine
derivatives
Prior art date
Application number
AT00984924T
Other languages
English (en)
Inventor
Thomas Ruhland
Christian Krog-Jensen
Mario Rottlaender
Gitte Mikkelsen
Kim Andersen
Ejner Knud Moltzen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Application granted granted Critical
Publication of ATE261959T1 publication Critical patent/ATE261959T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT00984924T 1999-12-30 2000-12-20 Substituierte phenyl-piperazin-derivate, deren herstellung und verwendung ATE261959T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199901885 1999-12-30
PCT/DK2000/000721 WO2001049678A1 (en) 1999-12-30 2000-12-20 Substituted phenyl-piperazine derivatives, their preparation and use

Publications (1)

Publication Number Publication Date
ATE261959T1 true ATE261959T1 (de) 2004-04-15

Family

ID=8108803

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00984924T ATE261959T1 (de) 1999-12-30 2000-12-20 Substituierte phenyl-piperazin-derivate, deren herstellung und verwendung

Country Status (28)

Country Link
US (1) US6699864B2 (de)
EP (1) EP1246816B1 (de)
JP (1) JP2003519224A (de)
KR (1) KR100790916B1 (de)
CN (1) CN1230432C (de)
AR (1) AR029428A1 (de)
AT (1) ATE261959T1 (de)
AU (1) AU2152101A (de)
BG (1) BG65262B1 (de)
BR (1) BR0016952A (de)
CA (1) CA2395705C (de)
CZ (1) CZ20022319A3 (de)
DE (1) DE60009155T2 (de)
EA (1) EA006071B1 (de)
ES (1) ES2213634T3 (de)
HU (1) HUP0203722A3 (de)
IL (2) IL150241A0 (de)
IS (1) IS2174B (de)
MX (1) MXPA02006223A (de)
NO (1) NO322666B1 (de)
NZ (1) NZ519647A (de)
PL (1) PL199351B1 (de)
PT (1) PT1246816E (de)
SK (1) SK9442002A3 (de)
TR (2) TR200400645T4 (de)
UA (1) UA72948C2 (de)
WO (1) WO2001049678A1 (de)
ZA (1) ZA200204814B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
DE10259244A1 (de) * 2002-12-17 2004-07-01 Merck Patent Gmbh N-(Indolethyl-)cycloamin-Verbindungen
UA81300C2 (en) * 2003-04-04 2007-12-25 Lundbeck & Co As H Derivates of 4-(2-fenilsulfanilfenil)-1,2,3,6-tetrahydropiridin as retarding agents of serotonin recapture
WO2004087156A1 (en) 2003-04-04 2004-10-14 H. Lundbeck A/S 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors
EP1701940B1 (de) 2003-12-23 2008-05-28 H.Lundbeck A/S 2-(1h-indolylsulfanyl)-benzylaminderivate als ssri
SE0400441D0 (sv) 2004-02-25 2004-02-25 Active Biotech Ab Novel Benzofurans and Indols
AR052308A1 (es) 2004-07-16 2007-03-14 Lundbeck & Co As H Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto
US7629473B2 (en) 2005-06-17 2009-12-08 H. Lundbeck A/S 2-(1H-indolylsulfanyl)-aryl amine derivatives
AR054393A1 (es) 2005-06-17 2007-06-20 Lundbeck & Co As H Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos.
MY150647A (en) 2006-06-16 2014-02-14 Lundbeck & Co As H 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment
EP2209380A4 (de) * 2007-10-09 2011-09-14 Mark T Hamann Verfahren zur verwendung von zusammensetzungen mit antidepressiver wirksamkeit, stimmungsaufhellender wirksamkeit und sonstiger neurologischer wirksamkeit und diesbezügliche zusammensetzungen
WO2009112139A1 (en) * 2008-03-14 2009-09-17 Merck Patent Gmbh, Azaindole compounds for treatment of central nervous system disorders
CN105283442B (zh) * 2013-04-04 2018-04-13 斯洛文尼亚莱柯制药股份有限公司 用于合成1‑(2‑((2,4‑二甲基苯基)硫代)苯基)哌嗪的方法
WO2015169180A1 (en) * 2014-05-04 2015-11-12 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods and use thereof
CN105085491B (zh) * 2014-05-05 2019-06-25 广东东阳光药业有限公司 取代的吲哚化合物及其使用方法和用途
CN106243088B (zh) 2015-06-03 2019-01-04 广东东阳光药业有限公司 取代的哌嗪化合物及其使用方法和用途
WO2017012579A1 (zh) * 2015-07-23 2017-01-26 广东东阳光药业有限公司 取代的吲哚化合物及其使用方法和用途
US11285153B2 (en) 2017-09-29 2022-03-29 Sunshine Lake Pharma Co., Ltd. Substituted pyrimidine piperazine compound and use thereof
CN111518012A (zh) * 2020-05-27 2020-08-11 中国药科大学 含苯硫醚结构的化合物或其药学上可接受的盐、制备方法和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2138865A1 (de) * 1970-08-15 1973-02-22 Sumitomo Chemical Co 3-indolylpiperazine, verfahren zu ihrer herstellung und arzneimittel
GB8830312D0 (en) * 1988-12-28 1989-02-22 Lundbeck & Co As H Heterocyclic compounds
AU6435594A (en) * 1993-04-15 1994-11-08 Merck Sharp & Dohme Limited Indole derivatives as dopamine d4 antagonists
FR2712591B1 (fr) * 1993-11-19 1996-02-09 Pf Medicament Nouvelles arylpipérazines dérivées d'indole, leur préparation et leur utilisation thérapeutique.
WO1997019039A1 (en) 1995-11-17 1997-05-29 Novartis Ag Solid phase synthesis of heterocyclic compounds and combinatorial compound library
USH2007H1 (en) * 1996-01-19 2001-12-04 Fmc Corporation Insecticidal N-heterocyclylalkyl-or N-[(polycyclyl)alkyl]-N′substituted piperazines
ES2128266B1 (es) * 1997-07-08 2000-01-16 Vita Invest Sa Compuestos derivados de tiofeno y benzotiofeno y utilizacion y composicion correspondientes.
DE60034571T2 (de) 1999-06-15 2007-12-27 Aventis Pharmaceuticals Inc. Festphasensynthese von n,n-disubstituierten diazacycloalkylcarboxy-derivaten
JP2003519227A (ja) * 1999-12-30 2003-06-17 ハー・ルンドベック・アクチエゼルスカベット 置換されたベンゼン誘導体の製造方法

Also Published As

Publication number Publication date
HUP0203722A3 (en) 2005-03-29
ZA200204814B (en) 2003-08-27
EP1246816B1 (de) 2004-03-17
IS6420A (is) 2002-06-13
SK9442002A3 (en) 2002-11-06
PT1246816E (pt) 2004-08-31
JP2003519224A (ja) 2003-06-17
ES2213634T3 (es) 2004-09-01
US20030125320A1 (en) 2003-07-03
PL199351B1 (pl) 2008-09-30
BG65262B1 (bg) 2007-10-31
AU2152101A (en) 2001-07-16
IS2174B (is) 2006-11-15
NO322666B1 (no) 2006-11-13
TR200201683T2 (tr) 2002-12-23
NZ519647A (en) 2004-02-27
EP1246816A1 (de) 2002-10-09
WO2001049678A1 (en) 2001-07-12
CA2395705A1 (en) 2001-07-12
CN1437597A (zh) 2003-08-20
US6699864B2 (en) 2004-03-02
EA200200732A1 (ru) 2003-02-27
EA006071B1 (ru) 2005-08-25
BG106930A (en) 2003-04-30
DE60009155D1 (de) 2004-04-22
BR0016952A (pt) 2002-10-08
PL355539A1 (en) 2004-05-04
CZ20022319A3 (cs) 2002-10-16
KR100790916B1 (ko) 2008-01-03
MXPA02006223A (es) 2002-12-05
UA72948C2 (uk) 2005-05-16
AR029428A1 (es) 2003-06-25
IL150241A (en) 2008-12-29
NO20023146L (no) 2002-06-28
HUP0203722A2 (hu) 2003-03-28
TR200400645T4 (tr) 2004-06-21
KR20020063287A (ko) 2002-08-01
IL150241A0 (en) 2002-12-01
CA2395705C (en) 2006-10-17
WO2001049678A9 (en) 2002-10-10
DE60009155T2 (de) 2005-01-05
CN1230432C (zh) 2005-12-07
NO20023146D0 (no) 2002-06-28

Similar Documents

Publication Publication Date Title
DE60336907D1 (de) Spirobifluorenderivate, deren herstellung und deren verwendung
DE59907961D1 (de) Indeno-, naphtho- und benzocyclohepta-dihydrothiazol derivate, deren herstellung und deren verwendung als anorektische arzneimittel
DE60034683D1 (de) 3(5)-ureido-pyrazolderivate, deren herstellungsverfahren und verwendung als krebshemmende mittel
DE69915693D1 (de) 2,5-diazabicyclo(2.2.1)heptanderivate, deren herstellung und deren verwendung in heilkunde
ATE258549T1 (de) Oxazolidindion-derivate, ihre herstellung und verwendung
DE69928140D1 (de) Antipicornavirale Verbindungen, deren Herstellung und Verwendung
DE69833223D1 (de) 4-aminothiazol derivate, deren herstellung und deren verwendung als inhibitoren cyclin-abhängiger kinasen
DE60209779D1 (de) Sulfonamidderivate, deren herstellung und deren verwendung als medikamente
ATE231869T1 (de) Pyridopyranoazepinderivate, ihre herstellung und therapeutische verwendung
DE60127434D1 (de) Benzoxazinonderivative, deren herstellung und verwendung
DE60009155D1 (de) Substituierte phenyl-piperazin-derivate, deren herstellung und verwendung
ATE302604T1 (de) Thienylazolylalkoxyethanamine, deren herstellung und deren verwendung als medikamente
DE60130834D1 (de) Zusammensetzungen gegen schlechte Gerüche, deren Herstellung und Verwendung
DE60323754D1 (de) Dioxan-2-alkylkarbamaten derivaten, deren herstellung und deren therapeutischen verwendung
ATE242197T1 (de) 3-amino-3-arylpropan-1-ol-derivate, deren herstellung und verwendung
DE60008419D1 (de) Farbstoffpräparate, deren herstellung und deren verwendung
DE50003761D1 (de) Indeno-dihydrothiazol derivate, deren herstellung und deren verwendung als anorektische arzneimittel
DE60005690D1 (de) Titanverbindungen, deren herstellung und verwendung
ATE312828T1 (de) Acylaminothiazolderivate, deren herstellung und deren therapeutische verwendung
ATE212346T1 (de) 3-substituierte tetrahydropyridopyrimidinon- derivate, ihre herstellung und verwendung
ATE329908T1 (de) Arylethene-sulfonamid derivate, deren herstellung und deren verwendung als endothelin-antagonisten
ATE249451T1 (de) Benzofuranderivate, ihre herstellung und verwendung
DE60012750D1 (de) Neue xanthon derivate, deren herstellung und verwendung als arzneimittel
DE59501950D1 (de) Isolongifolanol-Derivate, ihre Herstellung und ihre Verwendung
ATE240971T1 (de) Echinocandinderivate, deren herstellung und verwendung als fungizid

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1246816

Country of ref document: EP

REN Ceased due to non-payment of the annual fee